Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial

Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, Wilson H Miller, Rahima Jamal, Scott Ernst, Diane Logan, Karl Belanger, Khashayar Esfahani, Arielle Elkrief, Seema Nair Parvathy, Michael S Silverman, Bertrand Routy, Saman Maleki Vareki, John Gordon Lenehan

Open source

DOI: 10.1136/jitc-2025-012659
Published: 2025-08
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-012659,
  title = {Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial},
  author = {Danial Khan Hadi and Kelly J Baines and Behnam Jabbarizadeh and Wilson H Miller and Rahima Jamal and Scott Ernst and Diane Logan and Karl Belanger and Khashayar Esfahani and Arielle Elkrief and Seema Nair Parvathy and Michael S Silverman and Bertrand Routy and Saman Maleki Vareki and John Gordon Lenehan},
  year = {2025},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2025-012659},
  url = {https://doi.org/10.1136/jitc-2025-012659}
}

RIS

TY  - JOUR
TI  - Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
AU  - Danial Khan Hadi
AU  - Kelly J Baines
AU  - Behnam Jabbarizadeh
AU  - Wilson H Miller
AU  - Rahima Jamal
AU  - Scott Ernst
AU  - Diane Logan
AU  - Karl Belanger
AU  - Khashayar Esfahani
AU  - Arielle Elkrief
AU  - Seema Nair Parvathy
AU  - Michael S Silverman
AU  - Bertrand Routy
AU  - Saman Maleki Vareki
AU  - John Gordon Lenehan
PY  - 2025
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2025-012659
UR  - https://doi.org/10.1136/jitc-2025-012659
ER  -

APA

Hadi, D. K., Baines, K. J., Jabbarizadeh, B., Miller, W. H., Jamal, R., Ernst, S., Logan, D., Belanger, K., Esfahani, K., Elkrief, A., Parvathy, S. N., Silverman, M. S., Routy, B., Vareki, S. M., & Lenehan, J. G. (2025). Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012659

Source records

crossref · retrieved 2026-09-25T07:44:14.025Z